Finance

Lists
Why is MGX down 7,69%?
Dive Deeper
MGX:NASDAQ
Metagenomi Therapeutics Inc
US$1,02
-7,69%
(-0,085) 1D
US$1,02
+0,06% (+0,00060)
After hours
Closed: 2 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MGX...
Open
US$1,09
High
US$1,10
Low
US$1,02
Mkt. cap
38,36 ລ້ານ
Avg. vol.
149,22 ພັນ
Volume
121,95 ພັນ
52-wk high
US$3,95
52-wk low
US$1,02
EPS
US$-2,49
Shares outstanding
37,78 ລ້ານ
No. of employees
113
Open
US$1,09
High
US$1,10
Low
US$1,02
Mkt. cap
38,36 ລ້ານ
Avg. vol.
149,22 ພັນ
Volume
121,95 ພັນ
52-wk high
US$3,95
52-wk low
US$1,02
EPS
US$-2,49
Shares outstanding
37,78 ລ້ານ
No. of employees
113
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
37 ນາທີກ່ອນ
Phase 2 Trial Plans Could Be A Game Changer For Absci Stock (ABSI)
Simply Wall Street
Simply Wall Street
·
37 ນາທີກ່ອນ
3 U.S. Consumer Stocks That Could Benefit If Stimulus Checks Return
USA Today
USA Today
·
12 ຊົ່ວໂມງກ່ອນ
Is a stock market correction coming? Most Americans think so
About Metagenomi Therapeutics Inc
CEO-
Employees113
Founded2016
HeadquartersEmeryville, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to MGX in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MGX in the last 3 months.
Highest
Current US$1,02
US$7,00 (+586,27%)
Average
US$6,00 (+488,24%)
Lowest
US$5,00 (+390,20%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
J.P. Morgan
Hold
Maintained
-
-
08/17/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
08/11/2026
Yanan Zhu
Wells Fargo
Buy
Reiterated
US$7,00
+586,3%
08/11/2026
Keay Nakae
Chardan Capital
Buy
Maintained
US$5,00
+390,2%
08/10/2026
Geulah Livshits
Chardan Capital
Buy
Maintained
US$5,00
+390,2%
07/07/2026
Last report
10 ສ.ຫ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
US$-0,73 / US$-0,52
-40,38%miss
Revenue / Est. (USD)
-257,00 ພັນ / 2,93 ລ້ານ
-108,76%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
8,66 ລ້ານ
3,91 ລ້ານ
1,25 ລ້ານ
-257,00 ພັນ
Cost of goods sold
25,28 ລ້ານ
21,50 ລ້ານ
19,30 ລ້ານ
22,51 ລ້ານ
Cost of revenue
25,28 ລ້ານ
21,50 ລ້ານ
19,30 ລ້ານ
22,51 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,22 ລ້ານ
6,78 ລ້ານ
6,54 ລ້ານ
6,00 ລ້ານ
Operating expense
6,22 ລ້ານ
6,78 ລ້ານ
6,54 ລ້ານ
6,00 ລ້ານ
Total operating expenses
31,50 ລ້ານ
28,28 ລ້ານ
25,84 ລ້ານ
28,52 ລ້ານ
Operating income
-22,84 ລ້ານ
-24,37 ລ້ານ
-24,59 ລ້ານ
-28,77 ລ້ານ
Other non operating income
-2,00 ພັນ
-11,00 ພັນ
-1,00 ພັນ
35,00 ພັນ
EBT including unusual items
-20,63 ລ້ານ
-22,49 ລ້ານ
-23,05 ລ້ານ
-27,48 ລ້ານ
EBT excluding unusual items
-20,63 ລ້ານ
-22,49 ລ້ານ
-23,05 ລ້ານ
-27,48 ລ້ານ
Income tax expense
-234,00 ພັນ
34,00 ພັນ
10,00 ພັນ
-
Effective tax rate
1,13%
-0,15%
-0,04%
-
Other operating expenses
-
-
-
-
Net income
-20,39 ລ້ານ
-22,53 ລ້ານ
-23,06 ລ້ານ
-27,48 ລ້ານ
Net profit margin
-235,51%
-576,02%
-1.847,68%
10.693,39%
Earnings per share
-0,55
-0,60
-0,61
-0,73
Interest and investment income
2,21 ລ້ານ
1,88 ລ້ານ
1,54 ລ້ານ
1,26 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
2,21 ລ້ານ
1,88 ລ້ານ
1,54 ລ້ານ
1,26 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,52 ລ້ານ
-23,07 ລ້ານ
-23,31 ລ້ານ
-27,51 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google